We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OZK icon
2101
Bank OZK
OZK
$5.63B
$2.99M ﹤0.01%
109,779
-10,913
-9% -$303K
VVV icon
2102
Valvoline
VVV
$4.95B
$2.99M ﹤0.01%
135,810
-431
-0.3% -$9.25K
SKT icon
2103
Tanger
SKT
$4.67B
$2.99M ﹤0.01%
193,099
-2,360
-1% -$36.9K
CHH icon
2104
Choice Hotels
CHH
$5.01B
$2.99M ﹤0.01%
33,589
-11,238
-25% -$1M
PKX icon
2105
POSCO
PKX
$16B
$2.98M ﹤0.01%
63,285
-366,941
-85% -$17.2M
AUB icon
2106
Atlantic Union Bankshares
AUB
$6.08B
$2.98M ﹤0.01%
80,007
+22,731
+40% +$831K
HOMB icon
2107
Home BancShares
HOMB
$6.25B
$2.98M ﹤0.01%
158,572
+12,915
+9% +$241K
DAR icon
2108
Darling Ingredients
DAR
$9.51B
$2.97M ﹤0.01%
155,167
+32,410
+26% +$633K
CNR
2109
DELISTED
Cornerstone Building Brands, Inc.
CNR
$2.96M ﹤0.01%
489,627
+50,507
+12% +$276K
AVDV icon
2110
Avantis International Small Cap Value ETF
AVDV
$19B
$2.96M ﹤0.01%
+60,000
New +$2.97M
LFUS icon
2111
Littelfuse
LFUS
$11.2B
$2.95M ﹤0.01%
16,654
-3,884
-19% -$657K
GPMT
2112
Granite Point Mortgage Trust
GPMT
$70M
$2.95M ﹤0.01%
157,162
+27,301
+21% +$512K
CWST icon
2113
Casella Waste Systems
CWST
$5.85B
$2.94M ﹤0.01%
68,549
+6,003
+10% +$260K
EFOR
2114
Everforth Inc
EFOR
$1.25B
$2.93M ﹤0.01%
46,658
-596
-1% -$36.8K
SHLX
2115
DELISTED
Shell Midstream Partners, L.P.
SHLX
$2.93M ﹤0.01%
143,327
-98,988
-41% -$2.04M
BSX icon
2116
CALL
Boston Scientific
BSX
$70.8B
$2.93M ﹤0.01%
+72,000
New +$3.05M
EWU icon
2117
iShares MSCI United Kingdom ETF
EWU
$4.13B
$2.93M ﹤0.01%
93,244
+11,207
+14% +$349K
IBB icon
2118
PUT
iShares Biotechnology ETF
IBB
$9.2B
$2.92M ﹤0.01%
29,400
RPD icon
2119
Rapid7
RPD
$674M
$2.92M ﹤0.01%
64,448
+7,941
+14% +$446K
BMA icon
2120
Banco Macro
BMA
$5.92B
$2.92M ﹤0.01%
112,340
+13,575
+14% +$633K
FCNCA icon
2121
First Citizens BancShares
FCNCA
$25.1B
$2.92M ﹤0.01%
6,197
+5
+0.1% +$2.27K
ARWR icon
2122
Arrowhead Research
ARWR
$11.9B
$2.92M ﹤0.01%
103,492
+20,259
+24% +$600K
RDY icon
2123
Dr. Reddy's Laboratories
RDY
$10.1B
$2.92M ﹤0.01%
384,690
+135,675
+54% +$1.01M
DEA
2124
Easterly Government Properties
DEA
$1.16B
$2.91M ﹤0.01%
54,698
+6,964
+15% +$346K
SLF icon
2125
CALL
Sun Life Financial
SLF
$46B
$2.91M ﹤0.01%
+65,000
New +$2.72M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.